<DOC>
	<DOCNO>NCT00496054</DOCNO>
	<brief_summary>To observe safety , tolerability immunogenicity administration 3 dos rotateq healthy Indian infant 6 week exactly 12 week age entry .</brief_summary>
	<brief_title>Safety , Tolerability Immunogenicity Vaccination With Rotateq Healthy Infants India ( V260-021 )</brief_title>
	<detailed_description />
	<mesh_term>Gastroenteritis</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Age 6 week exactly 12 week Healthy infant Clinical evidence active gastrointestinal illness Fever , rectal temperature great equal thirty eight degree celsius time immunization History congenital abdominal disorder , intussusception , abdominal surgery History know prior rotavirus disease Known suspect impairment immunological function Prior administration rotavirus vaccine Known hypersensitivity component rotavirus vaccine , e.g . trypsin</criteria>
	<gender>All</gender>
	<minimum_age>6 Weeks</minimum_age>
	<maximum_age>12 Weeks</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>